Maher N. Younes

1.5k citations

21 papers · 1.1k indexed · h-index 19

Molecular Biology
Oncology top 5%
Endocrinology, Diabetes and Metabolism top 5%
Cancer Research top 10%
Pulmonary and Respiratory Medicine

Co-authors: Jeffrey N. Myers Samar A. Jasser Adel K. El‐Naggar Yasemin D. Yazici Seungwon Kim B. Nebiyou Bekele Orhan G. Yigitbasi Bradley A. Schiff
Topics: Thyroid Cancer Diagnosis and Treatment (10 papers)PI3K/AKT/mTOR signaling in cancer (5 papers)Melanoma and MAPK Pathways (3 papers)
Cited by: Endocrinology, Diabetes and Metabolism Oncology Immunology and Allergy
Journals: Cancer Research Oncogene Clinical Cancer Research
Partner nations: United States Canada China

In The Last Decade

Maher N. Younes

21 papers receiving 1.1k citations

Peers

Countries citing papers authored by Maher N. Younes

Since Specialization

Citations

This map shows the geographic impact of Maher N. Younes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maher N. Younes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maher N. Younes more than expected).

Fields of papers citing papers by Maher N. Younes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maher N. Younes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maher N. Younes. The network helps show where Maher N. Younes may publish in the future.

Co-authorship network of co-authors of Maher N. Younes

This figure shows the co-authorship network connecting the top 25 collaborators of Maher N. Younes. A scholar is included among the top collaborators of Maher N. Younes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maher N. Younes. Maher N. Younes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer 2019 ·Clinical Cancer Research ·Bradley A. Schiff,(unknown),Samar A. Jasser,Maher N. Younes,Dao Doan,Orhan G. Yigitbasi,Seungwon Kim,Ge Zhou,Mahitosh Mandal,B. Nebiyou Bekele,F. Christopher Holsinger,Steven I. Sherman,Sai‐Ching J. Yeung,Adel K. El‐Naggar,Jeffrey N. Myers	3
2	Dual inhibition of epidermal growth factor receptor and insulin‐like growth factor receptor I: Reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma 2010 ·Head & Neck ·Chad E. Galer,(unknown),Zhuoying Wang,Maher N. Younes,(unknown),Samar A. Jasser,Dale L. Ludwig,Adel K. El‐Naggar,Randal S. Weber,Jeffrey N. Myers	48
3	Branchiogenic carcinoma of a first branchial cleft cyst 2010 ·Otolaryngology ·Joseph P. Roche,Maher N. Younes,William K. Funkhouser,Mark C. Weissler	12
4	Reciprocal negative regulation between S100A7/psoriasin and β-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity 2008 ·Oncogene ·Ge Zhou,(unknown),Meina Zhao,S Jasser,Maher N. Younes,Daisuke Sano,Jing Lin,Michael E. Kupferman,Alfredo A. Santillan,V. Patel,J. Silvio Gutkind,(unknown),Ethan Emberley,Peter H. Watson,(unknown),John C. Reed,Jeffery N. Myers	49
5	Effects of the Integrin-Linked Kinase Inhibitor QLT0267 on Squamous Cell Carcinoma of the Head and Neck 2007 ·Archives of Otolaryngology - Head and Neck Surgery ·Maher N. Younes,Orhan G. Yigitbasi,Yasemin D. Yazici,Samar A. Jasser,Cora Bucana,Adel K. El‐Naggar,Gordon B. Mills,Jeffrey N. Myers	32
6	Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice 2007 ·Molecular Cancer Therapeutics ·Seungwon Kim,Yasemin D. Yazici,Gabriel Calzada,(unknown),Maher N. Younes,Samar A. Jasser,Adel K. El‐Naggar,Jeffrey N. Myers	113
7	The Tyrosine Kinase Inhibitor, AZD2171, Inhibits Vascular Endothelial Growth Factor Receptor Signaling and Growth of Anaplastic Thyroid Cancer in an Orthotopic Nude Mouse Model 2007 ·Clinical Cancer Research ·(unknown),(unknown),Maher N. Younes,Seung Won Kim,David Fooshee,Mei Zhao,Samar A. Jasser,Jeffrey N. Myers	36
8	The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck 2006 ·Oral Oncology ·Mahitosh Mandal,Maher N. Younes,(unknown),Samar A. Jasser,Dao Doan,Orhan G. Yigitbasi,(unknown),(unknown),Adel K. El‐Naggar,Cora Bucana,Gordon B. Mills,Jeffrey N. Myers	49
9	Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma 2006 ·Clinical Cancer Research ·Seung‐Hyun Oh,Woo‐Young Kim,(unknown),Maher N. Younes,Adel K. El‐Naggar,Jeffrey N. Myers,Merril Kies,Pinchas Cohen,Fadlo R. Khuri,Waun Ki Hong,Ho‐Young Lee	44
10	Growth-Inhibitory Effects of Human Anti-Insulin-Like Growth Factor-I Receptor Antibody (A12) in an Orthotopic Nude Mouse Model of Anaplastic Thyroid Carcinoma 2006 ·Clinical Cancer Research ·Zhuoying Wang,Geetika Chakravarty,Seungwon Kim,Yasemin D. Yazici,Maher N. Younes,Samar A. Jasser,Alfredo A. Santillan,Corazon D. Bucana,Adel K. El‐Naggar,Jeffrey N. Myers	34
11	Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model 2006 ·Molecular Cancer Therapeutics ·Maher N. Younes,Young Wook Park,Yasemin D. Yazici,(unknown),Alfredo A. Santillan,(unknown),Seungwon Kim,Samar A. Jasser,Adel K. El‐Naggar,Jeffrey N. Myers	54
12	Cetuximab and Irinotecan Interact Synergistically to Inhibit the Growth of Orthotopic Anaplastic Thyroid Carcinoma Xenografts in Nude Mice 2006 ·Clinical Cancer Research ·Seungwon Kim,(unknown),Maher N. Younes,Yasemin D. Yazici,Samar A. Jasser,B. Nebiyou Bekele,Jeffrey N. Myers	80
13	Dual Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor Inhibition with NVP-AEE788 for the Treatment of Aggressive Follicular Thyroid Cancer 2006 ·Clinical Cancer Research ·Maher N. Younes,Yasemin D. Yazici,Seungwon Kim,Samar A. Jasser,Adel K. El‐Naggar,Jeffrey N. Myers	27
14	AEE788, a Dual Tyrosine Kinase Receptor Inhibitor, Induces Endothelial Cell Apoptosis in Human Cutaneous Squamous Cell Carcinoma Xenografts in Nude Mice 2005 ·Clinical Cancer Research ·Young Wook Park,Maher N. Younes,Samar A. Jasser,Orhan G. Yigitbasi,Ge Zhou,Corazon D. Bucana,B. Nebiyou Bekele,Jeffrey N. Myers	48
15	Antivascular Therapy of Human Follicular Thyroid Cancer Experimental Bone Metastasis by Blockade of Epidermal Growth Factor Receptor and Vascular Growth Factor Receptor Phosphorylation 2005 ·Cancer Research ·Maher N. Younes,Orhan G. Yigitbasi,Young Wook Park,Sun-Jin Kim,Samar A. Jasser,Valerie Stone Hawthorne,Yasemin D. Yazici,Mahitosh Mandal,B. Nebiyou Bekele,Corazon D. Bucana,Isaiah J. Fidler,Jeffrey N. Myers	45
16	Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer 2005 ·Molecular Cancer Therapeutics ·Maher N. Younes,Seungwon Kim,Orhan G. Yigitbasi,Mahitosh Mandal,Samar A. Jasser,Yasemin D. Yazici,Bradley A. Schiff,Adel K. El‐Naggar,B. Nebiyou Bekele,Gordon B. Mills,Jeffrey N. Myers	74
17	Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer 2004 ·Clinical Cancer Research ·Bradley A. Schiff,(unknown),Samar A. Jasser,Maher N. Younes,Dao Doan,Orhan G. Yigitbasi,Seungwon Kim,Ge Zhou,Mahitosh Mandal,B. Nebiyou Bekele,F. Christopher Holsinger,Steven I. Sherman,Sai‐Ching J. Yeung,Adel K. El‐Naggar,Jeffrey N. Myers	142
18	Melanoma of the head and neck: current concepts in staging, diagnosis, and management 2004 ·Surgical Oncology Clinics of North America ·Maher N. Younes,Jeffrey N. Myers	26
19	Tumor Cell and Endothelial Cell Therapy of Oral Cancer by Dual Tyrosine Kinase Receptor Blockade 2004 ·Cancer Research ·Orhan G. Yigitbasi,Maher N. Younes,Dao Doan,Samar A. Jasser,Bradley A. Schiff,Corazon D. Bucana,B. Nebiyou Bekele,Isaiah J. Fidler,Jeffrey N. Myers	67
20	Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads to prolonged survival in a murine model of oral cancer. 2003 ·PubMed ·F. Christopher Holsinger,(unknown),Samar A. Jasser,(unknown),Jayson S. Greenberg,Bradley A. Schiff,B. Nebiyou Bekele,Maher N. Younes,Corazon D. Bucana,Isaiah J. Fidler,Jeffrey N. Myers	36

About Maher N. Younes

Maher N. Younes is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Immunology and Allergy, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (10 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (315 citations), Oncology (498 citations) and Immunology and Allergy (83 citations). Maher N. Younes has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Jeffrey N. Myers, Samar A. Jasser, Adel K. El‐Naggar, Yasemin D. Yazici, Seungwon Kim, B. Nebiyou Bekele, Orhan G. Yigitbasi, Bradley A. Schiff, Mahitosh Mandal and Corazon D. Bucana. Their work appears in journals such as Cancer Research, Oncogene and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact